DanielGruenerMD

Neurology • Philadelphia, PA

Pain Medicine

Physician

Join to view full profile

Dr. Gruener is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gruener's full profile

Already have an account?

Office
2833 Tyson Ave
Philadelphia, PA 19149
Phone+1 215-624-1300

Fax+1 215-624-7339

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Psychiatry, 1987 - 1991
American University of the Caribbean School of MedicineClass of 1984

Certifications & Licensure

MO State Medical License 2015 - 2026
NY State Medical License 2024 - 2026
PA State Medical License 1990 - 2024
NJ State Medical License 1991 - 2003
HI State Medical License 1990 - 1994
MI State Medical License 1990 - 1994
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Identigene STD Test Collection Kit Validation Study Start of enrollment: 2011 Nov 01
Unknown status
Phase 3
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) Start of enrollment: 2013 Nov 01
Unknown status
Not Applicable
A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD Start of enrollment: 2015 Dec 22
Completed
Phase 1
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes Start of enrollment: 2017 Sep 13
Completed
Not Applicable
Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression Start of enrollment: 2018 Jun 06
Completed
Phase 1
Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy Start of enrollment: 2018 Nov 15
Completed
Phase 2
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression Start of enrollment: 2024 May 28
Recruiting
Phase 2
Roles: Contact
BHV-7000 Acute Treatment of Bipolar Mania Start of enrollment: 2024 May 28
Recruiting
Phase 2, Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

17 citations
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4
Bradley D. Vince, J. Hill, Eric Lawitz, William O'Riordan, Lynn R. Webster
Journal of Hepatology. 2014-05-01
2 citations
Dietary vitamin B12 deficiency in a patient with multiple sclerosis
Daniel M. Gruener, Elisabeth J.S. Kunkel, Deborah A. Snyderman, M. Ruth Infante, Carla Rodgers
General Hospital Psychiatry. 1994-05-01